Short Talks > Session
Short Talks - Taking Lab Monitoring to the Next Level
Moderators
Kristi Smock, Prarthana Parthasarathy
Presentations
10:30 |
FACTOR II AND X (FIIX) MONITORED WARFARIN IS MORE EFFECTIVE THAN PT-INR MONITORED WARFARIN AND DIRECT ORAL ANTICOAGULANTS IN PATIENTS ANTICOAGULATED LONG-TERM FOR NON-VALVULAR ATRIAL FIBRILLATION. THE GREATER REYKJAVIK ORAL ANTICOAGULATION (GROAC) STUDY. Arnar B. Ingason1,2, Brynja R. Gudmundsdottir1, Ragnar Palsson1,3,4, Arnar S. Agustsson1, Edward Rumba1, Daniel A. Palsson1, Indridi Reynisson1, Sigrun H. Lund5, Johann P. Hreinsson6, Einar S. Bjornsson1,5, Pall T. Onundarson1,5. 1Landspitali National University Hospital, Reykjavik, Iceland 2University of Vermont, Burlington, VT, USA 3Massachusetts General Hospital, Boston, MA, USA 4Harvard University, Boston, MA, USA 5University of Iceland, Reykjavik, Iceland 6Sahlgrenska University, Gothenburg, Sweden |
|||
10:45 |
DROP-OF-BLOOD COAGULATION ANALYSIS BY I-QATTTM Huy Q Pham1, Collette Barnor1, Daishen Luo1, Elizabeth M Cummins1, Nithya Kasireddy1, Daniel Arango2, Shaun Yockelson3, Damir B Khismatullin1. 1Department of Biomedical Engineering, Tulane University, New Orleans, LA, USA 2The University of Texas Medical Branch, Galveston, TX, USA 3Department of Anesthesiology and Perioperative Medicine, Ochsner Medical Center, New Orleans, LA, USA |
|||
11:00 |
REAL-WORLD USE AND CORRELATION BETWEEN PLATELET-DEPENDANT ACTIVITY ASSAYS OF VON WILLEBRAND FACTOR (VWF):AB AND VWF:GP1BM IN PATIENTS WITH VON WILLEBRAND DISEASE IN THE AGE OF THE NEW GUIDELINES: A SINGLE-CENTER STUDY Prarthana Parthasarathy, Kerry M Hege. Riley Hospital for Children at IU Health, Indiana University School of Medicine, Indianapolis, IN, USA |
|||
11:15 |
ICOAGLAB PERMITS COMPREHENSIVE COAGULATION PROFILING IN PATIENTS ON PERCUTANEOUS CARDIAC PUMP SUPPORT Eli J Foster, Nathaniel Hai, Ziqian Zeng, Seemantini K Nadkarni. Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA |